PBYI vs TM · P/E 4.3, rev $56.5M vs P/E 9.7, rev $234.60B
Puma Biotechnology Inc (PBYI) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
Puma Biotechnology Inc (PBYI) is a biotechnology company listed on US.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Latest reported PBYI revenue for 2026-06-30 was $56.5M. Net income was $8.2M. Revenue was up 26.1% from 2026-03-31 to 2026-06-30. PBYI currently screens at market cap $165.3M and trailing P/E 4.3.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
PBYI currently screens at market cap $165.3M and trailing P/E 4.3. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the PBYI and TM stock pages for the full models.
Not investment advice.